German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N02CD" (14)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Erenumab (N02CD01) 2 products
WHO-DDD
L
IP
CI
Aimovig 70 mg/ml
1 ml
352.34
399.60
10 %
Injektionslösung im Fertigpen: Erenumabum 70 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Aimovig 140 mg/ml
1 ml
352.34
399.60
10 %
Injektionslösung im Fertigpen: Erenumabum 140 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
Galcanezumab (N02CD02) 2 products
WHO-DDD
L
IP
CI
Emgality 120 mg
1 ml
401.23
452.80
10 %
Injection solution in prefilled syringe: Galcanezumabum 120 mg/ml
Eli Lilly (Suisse) SA
B / SL
FB
G
IP
CI
Emgality 120 mg
2 x 1 ml
k.A.
Injection solution in prefilled syringe: Galcanezumabum 120 mg/ml
Eli Lilly (Suisse) SA
B
FB
G
Fremanezumab (N02CD03) 4 products
WHO-DDD
L
IP
CI
AJOVY 225 mg
1.5 ml
405.97
457.95
10 %
Injection solution in prefilled syringe: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B / SL
FB
G
L
IP
CI
AJOVY 225 mg
3 x 1.5 ml
1217.90
1340.95
10 %
Injection solution in prefilled syringe: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B / SL
FB
G
L
IP
CI
AJOVY 225 mg
1.5 ml
405.97
457.95
10 %
Injektionslösung im Fertigpen: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B / SL
FB
G
IP
CI
AJOVY 225 mg
3 x 1.5 ml
k.A.
Injektionslösung im Fertigpen: Fremanezumabum 225mg / 1.5ml
Teva Pharma AG
B
FB
G
Eptinezumab (N02CD05) 1 products
WHO-DDD
L
IP
Vyepti 100 mg/ml
1 ml
1141.21
1257.55
10 %
Concentrate for infusion: Eptinezumabum 100 mg/ml
Lundbeck (Schweiz) AG
B / SL
FB
G
Rimegepant (N02CD06) 3 products
WHO-DDD
L
IP
CI
Vydura 75 mg
2
41.48
61.55
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Vydura 75 mg
8
165.92
196.85
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Vydura 75 mg
16
331.84
377.30
10 %
Soluble Powder: Rimegepantum 75 mg
Pfizer AG
B / SL
FB
G
Atogepant (N02CD07) 2 products
WHO-DDD
L
IP
CI
AQUIPTA 10 mg
28
315.92
360.00
10 %
Tablets: Atogepantum 10 mg
AbbVie AG
B / SL
FB
G
L
IP
CI
AQUIPTA 60 mg
28
315.92
360.00
10 %
Tablets: Atogepantum 60 mg
AbbVie AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
